Carani Sanjeevi
Director/Board Member at Allarity Therapeutics Europe ApS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Buhl Jensen | M | 69 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 20 years |
| Gunnar Magnus Modee Persson | M | 64 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Karolinska Institutet
| 30 years |
| Duncan Moore | M | 65 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 9 years |
| Steen Meier Knudsen | M | 63 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 12 years |
| Peter Sackey | M | 53 |
Karolinska Institutet
| 4 years |
| Anna-Karin Edstedt Bonamy | M | 50 |
Karolinska Institutet
| 14 years |
| Lars-Olof Hansson | M | 80 |
Karolinska Institutet
| 30 years |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Claus Frisenberg Pedersen | M | 52 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 6 years |
| Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Han Jing Xie | M | 54 |
Karolinska Institutet
| 4 years |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Lajos Gunnar Németh | M | 72 |
Karolinska Institutet
| 21 years |
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 years |
| Per Magnus Gerde | M | - |
Karolinska Institutet
| - |
| Ewa Björling | M | 63 |
Karolinska Institutet
| - |
| Hans Ehrsson | M | - |
Karolinska Institutet
| - |
| Björn Allan Beermann | M | 83 |
Karolinska Institutet
| - |
| Jan Matthew Balmanno Carlstedt-Duke | M | 71 |
Karolinska Institutet
| - |
| Lars Ährlund-Richter | M | 72 |
Karolinska Institutet
| - |
| Kerstin Uvnäs Moberg | M | 80 |
Karolinska Institutet
| - |
| Jan Peter Andersson | M | 73 |
Karolinska Institutet
| 14 years |
| Hans Hassle | M | - |
Karolinska Institutet
| - |
| Tord Stefan Erik Arver | M | 72 |
Karolinska Institutet
| - |
| Scott Boyer | M | 62 |
Karolinska Institutet
| - |
| Magnus Jaderberg | M | - |
Karolinska Institutet
| - |
| Magnus Westgren | M | 73 |
Karolinska Institutet
| 18 years |
| Johan Edvard Lundin | M | 60 |
Karolinska Institutet
| 12 years |
| Håkan Mellstedt | M | 82 |
Karolinska Institutet
| 25 years |
| Bengt Ingemar Samuelsson | M | 90 |
Karolinska Institutet
| - |
| Marie Wickman-Chanteraeu | M | 69 |
Karolinska Institutet
| - |
| Martin Schalling | M | - |
Karolinska Institutet
| - |
| Rune Toftgard | M | - |
Karolinska Institutet
| - |
| Lena Von Koch | F | - |
Karolinska Institutet
| - |
| Susana Borrás | F | - |
Karolinska Institutet
| - |
| Anders Blanck | M | - |
Karolinska Institutet
| - |
| Petter Brodin | M | - |
Karolinska Institutet
| - |
| Caroline Ingre | M | 47 |
Karolinska Institutet
| - |
| Elias Arnér | M | - |
Karolinska Institutet
| - |
| Magnus Sjoegren | M | - |
Karolinska Institutet
| - |
| Peter Hjelmström | M | 51 |
Karolinska Institutet
| - |
| Knut Martin Henschen Ingvar | M | 69 |
Karolinska Institutet
| - |
| Märta Segerdahl | M | 68 |
Karolinska Institutet
| - |
| Eva Andersson-Dubin | M | - |
Karolinska Institutet
| - |
| Ronald Li | M | - |
Karolinska Institutet
| 8 years |
| Olle Kämpe | M | 68 |
Karolinska Institutet
| - |
| Joakim Tedroff | M | 63 |
Karolinska Institutet
| - |
| Pär Nordlund | M | 66 |
Karolinska Institutet
| 19 years |
| David Rikard Martinsson Holmdahl | M | 71 |
Karolinska Institutet
| 16 years |
| Hans Wiksell | M | - |
Karolinska Institutet
| - |
| Carl Johan Bertil Sundberg | M | 66 |
Karolinska Institutet
| - |
| Carola Elisabet Lemne | M | 66 |
Karolinska Institutet
| 26 years |
| Anders Olof Adolf Ekblom | M | 70 |
Karolinska Institutet
| - |
| Bo Angelin | M | 73 |
Karolinska Institutet
| - |
| Göran Tornling | M | 77 |
Karolinska Institutet
| - |
| Andris Kreicbergs | M | - |
Karolinska Institutet
| - |
| Sven-Erik Dahlén | M | - |
Karolinska Institutet
| - |
| Jonas Christopher Frisén | M | 58 |
Karolinska Institutet
| - |
| Rolf Lewensohn | M | - |
Karolinska Institutet
| - |
| Per M. Almqvist | M | - |
Karolinska Institutet
| - |
| Per Axel Tomas Södersten | M | 79 |
Karolinska Institutet
| - |
| Jan Orwar | M | 60 |
Karolinska Institutet
| - |
| Stig Gösta Ollmar | M | 78 |
Karolinska Institutet
| 27 years |
| Madeleine Olsson-Eriksson | M | 79 |
Karolinska Institutet
| - |
| Bo-Ragnar Tolf | M | 74 |
Karolinska Institutet
| - |
| Matti Sällberg | M | 63 |
Karolinska Institutet
| 24 years |
| Bernd Seizinger | M | 67 |
Karolinska Institutet
| - |
| Josef M. Miller | M | - |
Karolinska Institutet
| - |
| Håkan Elmqvist | M | - |
Karolinska Institutet
| - |
| Gert Auer | M | - |
Karolinska Institutet
| - |
| Torkel Klingberg | M | - |
Karolinska Institutet
| - |
| Sven Fredrik Lindskog | M | 71 |
Karolinska Institutet
| - |
| John Arne Øvretveit | M | - |
Karolinska Institutet
| - |
| John Wahren | M | - |
Karolinska Institutet
| - |
| Graham Lappin | M | - |
Karolinska Institutet
| - |
| Ulf de Faire | M | - |
Karolinska Institutet
| - |
| Mona Ståhle | M | - |
Karolinska Institutet
| - |
| Gunvor Ester Ekman-Ordeberg | M | 80 |
Karolinska Institutet
| 23 years |
| Lars Gunnar Lannfelt | M | 75 |
Karolinska Institutet
| 31 years |
| Jan Anders Holgersson | M | - |
Karolinska Institutet
| - |
| Erik Gustav Magnus Axelson | M | - |
Karolinska Institutet
| - |
| Edvard Smith | M | 73 |
Karolinska Institutet
| - |
| Erik Johan Frostegård | M | 65 |
Karolinska Institutet
| - |
| Gunilla Anders Ekström | M | 66 |
Karolinska Institutet
| - |
| Torgny H. Svensson | M | - |
Karolinska Institutet
| - |
| Klas Gosta Wiman | M | - |
Karolinska Institutet
| - |
| Peter Birk Rasmussen | M | 59 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | 9 years |
| Sten Nilsson | M | 76 |
Karolinska Institutet
| - |
| Lars Olson | M | - |
Karolinska Institutet
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henrik Kristian Moltke | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 1 years |
| Frank Knudsen | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| James Cullem | M | 56 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 4 years |
| Gail Maderis | F | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Alexander Ullrich von Gabain | M | 73 |
Karolinska Institutet
| 3 years |
| Niels Laursen | M | 68 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Steve Carchedi | M | 62 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Bita Sehat | F | - |
Karolinska Institutet
| 10 years |
| Søren Jensen | M | 61 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Amennai Beyeen | M | - |
Karolinska Institutet
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 88 | 88.00% |
| Denmark | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carani Sanjeevi
- Personal Network
